A cochlear implant is a medical device. A brain-computer interface that lets a paralyzed person move a cursor is therapeutic. A neural implant that enhances a healthy person's memory is... what, exactly? A gene edit that prevents a disease is medicine. A gene edit that increases intelligence is... enhancement? Each step individually looks like improvement. But the cumulative trajectory raises a question that most individual decisions do not: when does augmentation become redefinition?
The boundary between treatment and enhancement has never been clean. Eyeglasses correct a deficit. LASIK goes beyond baseline. Cosmetic surgery redesigns. Stimulants treat ADHD — and enhance focus in people without it. Each of these existed long before the current wave of augmentation technologies, and society has accommodated them without existential crisis.
What is different now is the depth and permanence of the modifications becoming possible. Brain-computer interfaces are moving toward not just restoring function but adding capabilities — direct neural access to information, enhanced sensory perception, communication at the speed of thought. Gene editing can modify the biological blueprint. Cognitive enhancement through psychedelics, nootropics, and eventually direct neural stimulation is advancing along multiple tracks simultaneously.
The equity dimension makes the question even harder. If augmentation is available to those who can afford it, we do not just get enhanced individuals — we get a stratified species. People with neural implants, optimized genomes, and pharmaceutical enhancements competing for jobs, status, and resources against people without them. This is not a distant scenario — it is the logical extension of current trends in unequal access to technology and healthcare.
Ghost in the Shell is the book's most sustained exploration of this question. Major Kusanagi's body is almost entirely cybernetic. Her brain is augmented. Her identity is inseparable from her technology. The film's central question — what is left that is essentially "her" when so much has been replaced — becomes increasingly practical as augmentation technologies advance from fiction to engineering.
The book's Human Dignity framework is not anti-augmentation. It asks a more subtle question: does the augmentation serve the person, or does it redefine the person in ways that serve someone else's purposes? The distinction matters. Restoring a paralyzed person's mobility serves the person. Enhancing soldiers' cognition for military advantage serves the institution. The technology may be similar, but the ethical calculus differs.
Power, Privilege, and Access — the book's persistent concern with who benefits — becomes a question about what kind of species we become. If Elysium imagined a two-tier society divided by access to medical technology, a world of augmented and unaugmented humans would be a version of that division written into biology itself.
The Human Dimension — the book's insistence that the human effects of technology are what ultimately matter — asks the simplest version of the question: do these augmentations make people's lives genuinely better? Not more productive, not more competitive, not more optimized — better?